Efficacy of nutritional supplement (Haras) on carbon monoxide levels in smokers and non-smokers: An observational study
Vidyadevi Chandavarkar, Mithilesh Narayan Mishra, Deepak Bhargava, Premalatha Bidadi Rajashekaraiah, Shafali Singh, Vijay Kanuru- Otorhinolaryngology
- Pathology and Forensic Medicine
- General Dentistry
Context:
Carbon monoxide (CO) concentrations in exhaled air may impart a quick, non-invasive method to determine smoking status. Haras is a nutraceutical medication, which is slowly gaining recognition for its antioxidant and anti-inflammatory activities.
Aims:
The effectiveness of the Haras therapy in smokers and non-smokers will be assessed by evaluating breath CO levels.
Methods and Materials:
The study included 101 test subjects with 76 subjects of smokers and 25 subjects of non-smokers. Both the test groups were given 10 mL of Haras juice in divided doses per day for 30 days. The CO levels were evaluated using a breath analyser before drug trial and then on the 8th, 15th, 22nd and after the conclusion of the drug trial.
Statistical Analysis Used:
The Wilcoxon signed-rank test was used to compare the CO and carboxyhemoglobin levels among smokers and non-smokers.
Results:
Smokers had higher mean percent carboxyhemoglobin and mean parts per million CO values than non-smokers, and the difference between the two was shown to be statistically significant (
Conclusions:
Haras can be used effectively as an alternative supportive treatment for the diminution of CO levels in smokers and non-smokers.